The annual Coverage for SCD Summit provides a collaborative forum to discuss the changing landscape of healthcare coverage for sickle cell disease (SCD). This meeting brings together payers, providers, pharmaceutical manufacturers, patient groups, researchers, care teams, and policymakers to discuss ways to tackle the complexities of coverage and access to SCD treatments and care.
This year’s event will feature sessions on:
— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Background
Sickle cell disease is a rare genetic disorder, affecting approximately 100,000 individuals in the U.S., and disproportionately affecting Black and Brown populations. Treatment advances are emerging, yet barriers to access contribute to underutilization. Racial inequities and health disparities add to poor health outcomes and gaps in access.
The Coverage for SCD Summit highlights best practices for payer management of sickle cell disease. Information on the complications of sickle cell disease, advances in current treatment options, and strategies to address racial health disparities through coverage policy are shared.
CE Credit
One of the event’s sessions will offer one hour of continued education (CE) credit. This CE credit session provides pharmacists, managed care specialists, and physicians the knowledge and skills they need to enhance their professional competence.
— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
For more information, download the full Program Book by clicking the button below.
Thank you to everyone who attended the 2023 Coverage for SCD Summit. For anyone that was unable to attend or would like to rewatch, the full event recording is available below.
Speakers are listed below in alphabetical order. Click on a speaker to view their bio and sessions.
Want to learn more about last year’s summit? You can find our previous agenda, speaker list and more HERE.